Zinc Fumarate

Zinc fumarate is an inorganic zinc salt formed by combining zinc ions with fumaric acid, a compound involved in the citric acid cycle. Unlike established zinc supplements such as zinc gluconate or zinc picolinate, zinc fumarate has no documented human clinical applications and is primarily studied in materials science and used as an animal feed additive.

Origin & History

Zinc fumarate is a synthetic compound formed by combining zinc ions with fumaric acid, a dicarboxylic acid derived from the Krebs cycle or produced industrially via catalytic isomerization of maleic acid. It is manufactured as an organic zinc additive primarily for animal feed, with the molecular formula C₄H₂O₄Zn and molecular weight approximately 179-181.5 g/mol.

Historical & Cultural Context

No evidence of zinc fumarate in traditional medicine systems exists, as it is a modern synthetic compound without historical use. The compound has no documented traditional or cultural applications.

Health Benefits

• No human health benefits have been clinically studied or documented in the available research
• Current research focuses solely on materials science applications (metal-organic frameworks)
• Only established use is as an animal feed additive
• No evidence quality available due to absence of human studies
• General zinc benefits may theoretically apply but are unconfirmed for this specific form

How It Works

Zinc fumarate dissociates into zinc cations (Zn²⁺) and fumarate anions upon dissolution, theoretically allowing zinc to participate in its established biological roles such as cofactor activity for over 300 metalloenzymes including carbonic anhydrase, alkaline phosphatase, and Cu/Zn superoxide dismutase. The fumarate component is a four-carbon dicarboxylate intermediate in the Krebs cycle, converted to malate via fumarase, though whether co-delivery of fumarate alongside zinc confers any synergistic metabolic advantage in humans has never been tested. No human receptor-binding, absorption kinetic, or bioavailability data specific to the fumarate chelation form currently exists in published literature.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on zinc fumarate were identified in the available sources. PubChem entries list general literature and patents but no linked PubMed PMIDs for human studies on this compound. Research appears limited to materials science applications rather than biomedical contexts.

Clinical Summary

As of the available published literature, zero human clinical trials have investigated zinc fumarate as a dietary supplement for any health outcome. Research featuring zinc fumarate is almost entirely confined to materials science, specifically its role in constructing metal-organic frameworks (MOFs) with applications in gas storage and catalysis. Animal feed studies have examined zinc fumarate's effect on growth performance in livestock, but these findings cannot be extrapolated to human supplementation dosing or efficacy. The complete absence of human pharmacokinetic, bioavailability, or intervention data means no evidence-based claims regarding efficacy or optimal dosage can be made.

Nutritional Profile

Zinc Fumarate is an organozinc compound consisting of zinc chelated with fumaric acid (a dicarboxylic organic acid). Elemental zinc content: approximately 28-30% by molecular weight (based on molecular formula ZnC4H2O4, MW ~179.4 g/mol). As a mineral supplement form, the primary nutritional component is ionic zinc (Zn²⁺), with fumarate serving as the organic ligand/counterion. Fumarate itself is an intermediate in the citric acid (Krebs) cycle and contributes negligible caloric or macronutrient value at supplemental doses. No measurable macronutrients (protein, fat, carbohydrate) are present in meaningful quantities. Bioavailability: Human bioavailability data is entirely absent from published literature; no comparative absorption studies versus zinc gluconate, zinc sulfate, zinc citrate, or zinc oxide have been conducted in humans. Theoretical bioavailability may be moderate-to-good based on the general principle that organic zinc chelates tend to be better absorbed than inorganic salts (e.g., zinc oxide), but this is entirely extrapolated and unconfirmed for this specific compound. Animal feed research suggests functional zinc delivery, but species-specific differences limit translation to human nutrition. No established Dietary Reference Intake (DRI) values exist for this specific zinc form.

Preparation & Dosage

No clinically studied dosage ranges are available as no human trials on zinc fumarate were found. The compound is described only as a bulk chemical or feed additive without standardization details for human use. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other zinc forms, vitamin C, copper, vitamin D, quercetin

Safety & Interactions

Because no human clinical trials have been conducted with zinc fumarate specifically, its safety profile, tolerability, and adverse event frequency in humans are entirely undocumented. General zinc toxicity thresholds established for other zinc forms suggest that chronic intake exceeding 40 mg elemental zinc per day (the adult Tolerable Upper Intake Level set by the NIH) can cause copper deficiency, impaired immune function, and gastrointestinal distress, but whether these thresholds apply equivalently to zinc fumarate is unconfirmed. Zinc salts broadly can interfere with absorption of tetracycline and quinolone antibiotics, and may interact with penicillamine and thiazide diuretics, though no interaction studies specific to the fumarate form exist. Pregnant and breastfeeding individuals should avoid zinc fumarate given the complete absence of safety data for this specific compound in human populations.